City
Epaper

Clinovo taps Life Sciences executive Nandish Poluru as its next chief executive officer

By ANI | Updated: August 19, 2022 13:00 IST

Clinovo, a technology-focused Clinical services provider that accelerates Clinical Development for Life Sciences industry appoints Nandish Poluru as Chief Executive Officer effective immediately.

Open in App

Clinovo, a technology-focused Clinical services provider that accelerates Clinical Development for Life Sciences industry appoints Nandish Poluru as Chief Executive Officer effective immediately.

As an executive at the intersection of Lifesciences, Operations and Technology, Nandish has over two decades of experience in successfully accelerating Research and Development efforts for multiple companies across the Lifesciences industry. He brings expertise across the pharmaceutical value chain including Clinical Development and Operations, Clinical Data Management, Biostatistics and programming, Pharmacovigilance, Regulatory Operations and Technology.

Most recently, Nandish was the Vice President of Clinical Innovation at Bristol Myers Squibb (BMS) where he led efforts to accelerate Clinical Research globally with a focus on Digital Health, Patient Centricity, and Speed to Market. During his tenure at BMS, he also served in various roles to modernize Clinical Development through process and digital solutions. Prior to BMS, Nandish was Executive Director at Allergan (an Abbvie company) and worked at Forest Laboratories in various roles. He also worked in Silicon Valley at the start of his career.

"It is with great excitement and immense pleasure that I welcome Nandish to Clinovo" said Vamsi Maddipatla, President and Chairman at Clinovo. "Nandish is a visionary and innovative leader who brings demonstrated experience and skills along with exceptional leadership abilities. He is uniquely positioned to lead us in our next phase of growth and establish Clinovo as a global leader in the Clinical solutions market".

"I am very excited to join and work with the talented team at Clinovo" said Nandish. "I am thrilled to build on the strong foundations already established and lead the company to further scale the capabilities. I strongly believe that Clinovo is well positioned to create value for our customers by accelerating Clinical trials globally and bring new medicines to market faster."

Nandish has an MBA from Yale school of Management with a focus on Healthcare Management. He also has a Master's in information systems from Cleveland State University and a Bachelor`s in Electrical Engineering from Sri Venkateswara University, India.

Clinovo works with life sciences customers across the globe to accelerate clinical development and bring new medicines to market faster. Together with their customers, they focus on speed to submissions, decrease clinical development cycle times and lower development costs.

CONTACT:

This story is provided by PRNewswire.will not be responsible in any way for the content of this article. (ANI/PRNewswire)

( With inputs from ANI )

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: Clinical development for life sciencesOperations and technologyVamsi maddipatlaindiaValleyValleIndiUk-indiaRepublic of indiaIndia indiaGia indiaIndia eu
Open in App

Related Stories

NationalIndia Extends Airspace Ban on Pakistan-Based Aircraft Till July 24

NationalOperation Sindhu: “We Saw Drones, Missiles,” Say Evacuated Students Recounting Life in Iran’s Warzone

NationalCOVID-19 Update: Mumbai Cases Drop Sharply; India’s Active Tally Drops By 428

CricketIndia vs India A Intra-Squad LIVE Streaming: When and Where To Watch Intra-Squad Match on TV and Online?

Navi MumbaiNavi Mumbai News: Border Crackdown Forces Indian Woman to Part With Children and Husband Amid Citizenship Chaos

Business Realted Stories

BusinessElectricity futures contracts will help control power costs: NSE

BusinessSonowal inaugurates India’s first NBFC for maritime sector

BusinessAmitabh Kant joins Fairfax Financial Holdings as Senior Advisor, to help boost Indian investment

BusinessDIIs invest Rs 3.5 lakh crore in Indian stock market in first half of 2025

BusinessNTPC’s 3,300-MW power plant in Bihar to go fully operational from July 1